Crew Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
17,871
+964
+6% +$60.9K 0.59% 53
2026
Q2
$974K Buy
+16,907
New +$971K 0.53% 54
2024
Q1
– Sell
-5,195
Closed -$267K – 121
2023
Q4
$267K Sell
5,195
-396
-7% -$20.8K 0.27% 69
2023
Q3
$325K Sell
5,591
-1,672
-23% -$102K 0.35% 55
2023
Q2
$464K Sell
7,263
-1,870
-20% -$125K 0.53% 41
2023
Q1
$633K Sell
9,133
-700
-7% -$49.4K 0.91% 31
2022
Q4
$707K Sell
9,833
-450
-4% -$33.9K 1.02% 26
2022
Q3
$731K Sell
10,283
-250
-2% -$18.1K 1% 24
2022
Q2
$811K Sell
10,533
-150
-1% -$11.4K 1.02% 24
2022
Q1
$780K Sell
10,683
-200
-2% -$13.4K 0.75% 35
2021
Q4
$679K Sell
10,883
-800
-7% -$46.9K 0.57% 39
2021
Q3
$691K Sell
11,683
-250
-2% -$16.5K 0.64% 37
2021
Q2
$797K Sell
11,933
-100
-0.8% -$6.52K 0.74% 37
2021
Q1
$760K Buy
+12,033
New +$749K 0.76% 39

Other funds holding BMY

Crew Capital Management's BMY Position: Q3 2026 in Review

Crew Capital Management increased its Bristol-Myers Squibb (BMY) stake by 5.7% in Q3 2026, buying an estimated $60.9K and bringing the position to 17,871 shares worth $1.12M. The position accounts for 0.59% of the portfolio, ranked #53.

Crew Capital Management first reported a position in BMY in Q1 2021 and has held it in 14 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Crew Capital Management held 17,871 shares of Bristol-Myers Squibb worth $1.12M as of Q3 2026.
  • Crew Capital Management bought 964 Bristol-Myers Squibb shares in Q3 2026, an estimated $60.9K.
  • Bristol-Myers Squibb made up 0.59% of Crew Capital Management's portfolio in Q3 2026, its #53 holding.
  • Crew Capital Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 14 quarters since.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Crew Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.